Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial.
Saved in:
| Title: | Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial. |
|---|---|
| Authors: | Schwarz TF; Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Germany., Hwang SJ; En Chu Kong Hospital, New Taipei City, and Taipei Veterans General Hospital and School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Ylisastigui P; Alliance for Multispecialty Research, Fort Myers, Florida., Liu CS; China Medical University and China Medical University Hospital, Taichung, Taiwan., Takazawa K; Medical Corporation Shinanokai, Shinanozaka Clinic, Tokyo, Japan., Yono M; Nishi-Kumamoto Hospital, Kumamoto, Japan., Ervin JE; Alliance for Multispecialty Research, Kansas City, Missouri., Andrews CP; IMA Research San Antonio, Texas., Fogarty C; Spartanburg Medical Research, South Carolina., Eckermann T; Praxis Dr med Irmgard Maier-Bosse, Munich, Germany., Collete D; GSK, Rixensart, Belgium., de Heusch M; GSK, Wavre, Belgium., De Schrevel N; GSK, Rixensart, Belgium., Salaun B; GSK, Rixensart, Belgium., Lambert A; GSK, Wavre, Belgium., Maréchal C; GSK, Wavre, Belgium., Olivier A; GSK, Wavre, Belgium., Nakanwagi P; GSK, Wavre, Belgium., Lievens M; GSK, Wavre, Belgium., Hulstrøm V; GSK, Wavre, Belgium. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2024 Jul 25; Vol. 230 (1), pp. e102-e110. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39052726 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schwarz+TF%22">Schwarz TF</searchLink>; Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Germany.<br /><searchLink fieldCode="AU" term="%22Hwang+SJ%22">Hwang SJ</searchLink>; En Chu Kong Hospital, New Taipei City, and Taipei Veterans General Hospital and School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Ylisastigui+P%22">Ylisastigui P</searchLink>; Alliance for Multispecialty Research, Fort Myers, Florida.<br /><searchLink fieldCode="AU" term="%22Liu+CS%22">Liu CS</searchLink>; China Medical University and China Medical University Hospital, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Takazawa+K%22">Takazawa K</searchLink>; Medical Corporation Shinanokai, Shinanozaka Clinic, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yono+M%22">Yono M</searchLink>; Nishi-Kumamoto Hospital, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Ervin+JE%22">Ervin JE</searchLink>; Alliance for Multispecialty Research, Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Andrews+CP%22">Andrews CP</searchLink>; IMA Research San Antonio, Texas.<br /><searchLink fieldCode="AU" term="%22Fogarty+C%22">Fogarty C</searchLink>; Spartanburg Medical Research, South Carolina.<br /><searchLink fieldCode="AU" term="%22Eckermann+T%22">Eckermann T</searchLink>; Praxis Dr med Irmgard Maier-Bosse, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Collete+D%22">Collete D</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22de+Heusch+M%22">de Heusch M</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Schrevel+N%22">De Schrevel N</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Salaun+B%22">Salaun B</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Lambert+A%22">Lambert A</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Maréchal+C%22">Maréchal C</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Olivier+A%22">Olivier A</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Nakanwagi+P%22">Nakanwagi P</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Lievens+M%22">Lievens M</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Hulstrøm+V%22">Hulstrøm V</searchLink>; GSK, Wavre, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2024 Jul 25; Vol. 230 (1), pp. e102-e110. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39052726 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiad546 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e102 Titles: – TitleFull: Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schwarz TF – PersonEntity: Name: NameFull: Hwang SJ – PersonEntity: Name: NameFull: Ylisastigui P – PersonEntity: Name: NameFull: Liu CS – PersonEntity: Name: NameFull: Takazawa K – PersonEntity: Name: NameFull: Yono M – PersonEntity: Name: NameFull: Ervin JE – PersonEntity: Name: NameFull: Andrews CP – PersonEntity: Name: NameFull: Fogarty C – PersonEntity: Name: NameFull: Eckermann T – PersonEntity: Name: NameFull: Collete D – PersonEntity: Name: NameFull: de Heusch M – PersonEntity: Name: NameFull: De Schrevel N – PersonEntity: Name: NameFull: Salaun B – PersonEntity: Name: NameFull: Lambert A – PersonEntity: Name: NameFull: Maréchal C – PersonEntity: Name: NameFull: Olivier A – PersonEntity: Name: NameFull: Nakanwagi P – PersonEntity: Name: NameFull: Lievens M – PersonEntity: Name: NameFull: Hulstrøm V IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 07 Text: 2024 Jul 25 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 230 – Type: issue Value: 1 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |
